Table 2.
Prescription rate of GDMTs according to whether saltSub recommendations were provided by HCPs in France
| Number of prescriptions, n (%) | |||
|---|---|---|---|
| saltSub recommended by HCPs, n = 157 | saltSub not recommended by HCPs, n = 1105 | HCPs overall, n = 1262 | |
| No GDMTs a | 10 (6) | 58 (5) | 68 (5) |
| One GDMT | 37 (24) | 168 (15) | 168 (13) |
| Two GDMTs | 42 (27) | 355 (32) | 397 (31) |
| All three GDMTs | 68 (43) | 524 (47) | 592 (47) |
GDMTs, guideline‐directed medical therapies; HCPs, healthcare professionals; saltSub, salt substitute.
a
GDMTs included (i) angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers or angiotensin receptor–neprilysin inhibitors, (ii) mineralocorticoid receptor antagonists, and/or (iii) beta‐blockers.